ENTITY
AptaBio Therapeutics

AptaBio Therapeutics (293780 KS)

23
Analysis
Health Care • South Korea
Aptabio Therapeutics Inc. operates pharmaceutical production businesses. The Company produces anticancer drugs and other pharmaceutical products. Aptabio Therapeutics conducts businesses in Korea.
more
Exchange Announcement • 02 Sep 2026 14:44

Organization of Investor Relations Event

Exchange Announcement • 16 Jun 2026 11:22

Material Management Information related to Judgment of Investment(ABF101의 경구투여 시 ì•ˆì „ì„±, 내약성 및 약동학을 평가하기 위한 단회 및 반복 투여, ë‹¨ê³„ì  용량증량, ì œ1상 임상시험에 대한 미국 FDA Remove Clinical Hold 공문 ìˆ˜ë ¹)

Exchange Announcement • 14 Apr 2026 16:33

Material Management Information related to Judgment of Investment(IND Approval Determination)(ì¡°ì˜ì œìœ ë°œê¸‰ì„±ì‹ ìž¥ì†ìƒ(CIAKI)ì¹˜ë£Œì œ Isuzinaxib(APX115)의 미국 FDA 2상 임상시험계획(IND)변경승인)

Exchange Announcement • 06 Apr 2026 13:55

Organization of Investor Relations Event

Exchange Announcement • 31 Mar 2026 15:05

Outcomes of Annual Meeting of Shareholders

x